InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the full record of transactions filed by 王继华, Directeur. Insider active across 1 company, notably 万孚生物. In total, 6 filings have been logged. History available since 7 June 2021. The latest transaction was disclosed on 5 August 2026 (Purchase). Regulator: SSE / SZSE (CSRC). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Wang Jihua is a director at Wanfu Bio, where he is involved in strategic decision-making and operational management. With a solid background in the industry, he contributes to innovation and continuous process improvement. His commitment to operational excellence is an asset to the company.